# Cyclosporine and Prognosis in Acute Myocardial Infarction (MI) Patients

Study · id `cardio:ct-nct01502774` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01502774](<https://clinicaltrials.gov/study/NCT01502774>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01502774

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 970 participants.

## Technical summary

Registry record NCT01502774. Randomized; quadruple masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2015-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 970 participants (enrolled count; ClinicalTrials.gov record NCT01502774, source copy `cardio:ctgov-nct01502774-2025-09-04`, retrieved 2026-10-26)
- Start date: 2011-04 (registry gives no type) (ClinicalTrials.gov record NCT01502774, source copy `cardio:ctgov-nct01502774-2025-09-04`, retrieved 2026-10-26)
- Primary completion: 2015-02 (actual) (ClinicalTrials.gov record NCT01502774, source copy `cardio:ctgov-nct01502774-2025-09-04`, retrieved 2026-10-26)
- Completion: 2015-02 (actual) (ClinicalTrials.gov record NCT01502774, source copy `cardio:ctgov-nct01502774-2025-09-04`, retrieved 2026-10-26)
- Countries: Belgium; France; Spain (ClinicalTrials.gov record NCT01502774, source copy `cardio:ctgov-nct01502774-2025-09-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01502774-2025-09-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Cyclosporine and Prognosis in Acute Myocardial Infarction (MI) Patients
- Acronym: CIRCUS
- Condition: ST Elevation Acute Myocardial Infarction
- Intervention (Drug): Injection of Cyclosporin
- Intervention (Drug): Placebo
- Intervention (Procedure): Echocardiography
- Lead sponsor: Hospices Civils de Lyon
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Hospices Civils de Lyon (`cardio:org-hospices-civils-de-lyon`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Cyclosporine before PCI in Patients with Acute Myocardial Infarction (`cardio:pubmed-26321103`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Importance of infarct size versus other variables for clinical outcomes after PPCI in STEMI patients (`cardio:pubmed-31832789`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c7237746d77254ddb5f613a959a1588ad15fe00a3cbd79fb132175e32e093beb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
